Skip to main content

Progress and prospects for targeting Hsp90 to treat fungal infections

  • AMANDA VERI (a1) and LEAH E. COWEN (a1)

Fungal pathogens pose a major threat to human health worldwide. They infect billions of people each year, leading to at least 1·5 million deaths. Treatment of fungal infections is difficult due to the limited number of clinically useful antifungal drugs, and the emergence of drug resistance. A promising new strategy to enhance the efficacy of antifungal drugs and block the evolution of drug resistance is to target the molecular chaperone Hsp90. Pharmacological inhibitors of Hsp90 function that are in development as anticancer agents have potential to be repurposed as agents for combination antifungal therapy for some applications, such as biofilm infections. For systemic infections, however, effective combination therapy regimens may require Hsp90 inhibitors that can selectively target Hsp90 in the pathogen, or alternate strategies to compromise function of the Hsp90 chaperone machine. Selectively impairing Hsp90 function in the pathogen could in principle be achieved by targeting Hsp90 co-chaperones or regulators of Hsp90 function that are more divergent between pathogen and host than Hsp90. Antifungal combination therapies could also exploit downstream effectors of Hsp90 that are critical for fungal drug resistance and virulence. Here, we discuss the progress and prospects for establishing Hsp90 as an important therapeutic target for life-threatening fungal infections.

Corresponding author
* Corresponding author: Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Medical Sciences Building, Room 4368, Toronto, Ontario M5S 1A8, Canada. E-mail:
Hide All
Bader, T., Bodendorfer, B., Schroppel, K. and Morschhauser, J. (2003). Calcineurin is essential for virulence in Candida albicans . Infection and Immunity 71, 53445354.
Blankenship, J. R. and Mitchell, A. P. (2006). How to build a biofilm: a fungal perspective. Current Opinion in Microbiology 9, 588594.
Blankenship, J. R., Steinbach, W. J., Perfect, J. R. and Heitman, J. (2003). Teaching old drugs new tricks: reincarnating immunosuppressants as antifungal drugs. Current Opinion in Investigational Drugs 4, 192199.
Bock, C. and Lengauer, T. (2012). Managing drug resistance in cancer: lessons from HIV therapy. Nature Reviews Cancer 12, 494501. doi: 10.1038/nrc3297.
Brown, G. D., Denning, D. W., Gow, N. A., Levitz, S. M., Netea, M. G. and White, T. C. (2012 a). Hidden killers: human fungal infections. Science Translational Medicine 4, 165rv113. doi: 10.1126/scitranslmed.3004404.
Brown, G. D., Denning, D. W. and Levitz, S. M. (2012 b). Tackling human fungal infections. Science 336, 647. doi: 10.1126/science.1222236.
Bruno, V. M. and Mitchell, A. P. (2005). Regulation of azole drug susceptibility by Candida albicans protein kinase CK2. Moecular Microbiology 56, 559573.
Byrnes, E. J. III, Bartlett, K. H., Perfect, J. R. and Heitman, J. (2011). Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes and Infection 13, 895907. doi: 10.1016/j.micinf.2011.05.009.
Centers for Disease Control and Prevention (2013). Antibiotic Resistance Threats in the United States, 2013. U.S. Deparment of Health and Human Services. Centers for Disease Control and Prevention, Atlanta, USA.
Chan, C. T., Reeves, R. E., Geller, R., Yaghoubi, S. S., Hoehne, A., Solow-Cordero, D. E., Chiosis, G., Massoud, T. F., Paulmurugan, R. and Gambhir, S. S. (2012). Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects. Proceedings of the National Academy of Sciences USA 109, E2476E2485. doi: 10.1073/pnas.1205459109.
Chen, Y. L., Brand, A., Morrison, E. L., Silao, F. G., Bigol, U. G., Malbas, F. F. Jr., Nett, J. E., Andes, D. R., Solis, N. V., Filler, S. G., Averette, A. and Heitman, J. (2011). Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis . Eukaryotic Cell 10, 803819. doi: 10.1128/EC.00310-10.
Chen, Y. L., Konieczka, J. H., Springer, D. J., Bowen, S. E., Zhang, J., Silao, F. G., Bungay, A. A., Bigol, U. G., Nicolas, M. G., Abraham, S. N., Thompson, D. A., Regev, A. and Heitman, J. (2012). Convergent evolution of calcineurin pathway roles in thermotolerance and virulence in Candida glabrata . G3:Genes, Genomes, Genetics 2, 675691. doi: 10.1534/g3.112.002279.
Chen, Y. L., Lehman, V. N., Lewit, Y., Averette, A. F. and Heitman, J. (2013). Calcineurin governs thermotolerance and virulence of Cryptococcus gattii . G3:Genes, Genomes, Genetics 3, 527539. doi: 10.1534/g3.112.004242.
Cowen, L. E. (2008). The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype. Nature Reviews Microbiology 6, 187198.
Cowen, L. E. (2009). Hsp90 orchestrates stress response signaling governing fungal drug resistance. PLoS Pathogens 5, e1000471. doi: 10.1371/journal.ppat.1000471.
Cowen, L. E. (2013). The fungal Achilles’ heel: targeting Hsp90 to cripple fungal pathogens. Current Opinion in Microbiology 16, 377384. doi: 10.1016/j.mib.2013.03.005.
Cowen, L. E. and Lindquist, S. (2005). Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science 309, 21852189.
Cowen, L. E. and Steinbach, W. J. (2008). Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance. Eukaryotic Cell 7, 747764.
Cowen, L. E., Carpenter, A. E., Matangkasombut, O., Fink, G. R. and Lindquist, S. (2006). Genetic architecture of Hsp90-dependent drug resistance. Eukaryotic Cell 5, 21842188.
Cowen, L. E., Singh, S. D., Kohler, J. R., Collins, C., Zaas, A. K., Schell, W. A., Aziz, H., Mylonakis, E., Perfect, J. R., Whitesell, L. and Lindquist, S. (2009). Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proceedings of the National Academy of Sciences USA 106, 2828–2823. doi: 10.1073/pnas.0813394106.
Cruz, M. C., Goldstein, A. L., Blankenship, J. R., Del Poeta, M., Davis, D., Cardenas, M. E., Perfect, J. R., McCusker, J. H. and Heitman, J. (2002). Calcineurin is essential for survival during membrane stress in Candida albicans . EMBO Journal 21, 546559.
d'Enfert, C. (2006). Biofilms and their role in the resistance of pathogenic Candida to antifungal agents. Current Drug Targets 7, 465470.
Diezmann, S., Michaut, M., Shapiro, R. S., Bader, G. D. and Cowen, L. E. (2012). Mapping the Hsp90 genetic interaction network in Candida albicans reveals environmental contingency and rewired circuitry. PLoS Genetics 8, e1002562. doi: 10.1371/journal.pgen.1002562.
Donlin, L. T., Andresen, C., Just, S., Rudensky, E., Pappas, C. T., Kruger, M., Jacobs, E. Y., Unger, A., Zieseniss, A., Dobenecker, M. W., Voelkel, T., Chait, B. T., Gregorio, C. C., Rottbauer, W., Tarakhovsky, A. and Linke, W. A. (2012). Smyd2 controls cytoplasmic lysine methylation of Hsp90 and myofilament organization. Genes and Development 26, 114119. doi: 10.1101/gad.177758.111.
Eastman, R. T. and Fidock, D. A. (2009). Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nature Reviews Microbiology 7, 864874. doi: 10.1038/nrmicro2239.
Falsone, S. F., Leptihn, S., Osterauer, A., Haslbeck, M. and Buchner, J. (2004). Oncogenic mutations reduce the stability of SRC kinase. Journal of Molecular Biology 344, 281291.
Finkel, J. S. and Mitchell, A. P. (2011). Genetic control of Candida albicans biofilm development. Nature Reviews Microbiology 9, 109118. doi: 10.1038/nrmicro2475.
Fisher, M. C., Henk, D. A., Briggs, C. J., Brownstein, J. S., Madoff, L. C., McCraw, S. L. and Gurr, S. J. (2012). Emerging fungal threats to animal, plant and ecosystem health. Nature 484, 186194. doi: 10.1038/nature10947.
Gerik, K. J., Donlin, M. J., Soto, C. E., Banks, A. M., Banks, I. R., Maligie, M. A., Selitrennikoff, C. P. and Lodge, J. K. (2005). Cell wall integrity is dependent on the PKC1 signal transduction pathway in Cryptococcus neoformans . Molecular Microbiology 58, 393408. doi: 10.1111/j.1365-2958.2005.04843.x.
Gow, N. A., van de Veerdonk, F. L., Brown, A. J. and Netea, M. G. (2012). Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nature Reviews Microbiology 10, 112122. doi: 10.1038/nrmicro2711.
Imai, J. and Yahara, I. (2000). Role of HSP90 in salt stress tolerance via stabilization and regulation of calcineurin. Molecular and Cellular Biology 20, 92629270.
Jarosz, D. F. and Lindquist, S. (2010). Hsp90 and environmental stress transform the adaptive value of natural genetic variation. Science 330, 18201824. doi: 10.1126/science.1195487.
Johnson, J. L. and Brown, C. (2009). Plasticity of the Hsp90 chaperone machine in divergent eukaryotic organisms. Cell Stress and Chaperones 14, 8394. doi: 10.1007/s12192-008-0058-9.
Juvvadi, P. R., Gehrke, C., Fortwendel, J. R., Lamoth, F., Soderblom, E. J., Cook, E. C., Hast, M. A., Asfaw, Y. G., Moseley, M. A., Creamer, T. P. and Steinbach, W. J. (2013). Phosphorylation of calcineurin at a novel serine-proline rich region orchestrates hyphal growth and virulence in Aspergillus fumigatus . PLoS Pathogens 9, e1003564. doi: 10.1371/journal.ppat.1003564.
Kovacs, J. J., Murphy, P. J., Gaillard, S., Zhao, X., Wu, J. T., Nicchitta, C. V., Yoshida, M., Toft, D. O., Pratt, W. B. and Yao, T. P. (2005). HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Molecular and Cellular Biology 18, 601607.
LaFayette, S. L., Collins, C., Zaas, A. K., Schell, W. A., Betancourt-Quiroz, M., Gunatilaka, A. A., Perfect, J. R. and Cowen, L. E. (2010). PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90. PLoS Pathogens 6, e1001090. doi: 10.1371/journal.ppat.1001069.
Lamoth, F., Juvvadi, P. R., Gehrke, C. and Steinbach, W. J. (2012). In vitro activity of calcineurin and heat-shock protein 90 (Hsp90) inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains. Antimicrobial Agents and Chemotherapy 57, 10351039. doi: 10.1128/AAC.01857-12.
Leach, M. D., Klipp, E., Cowen, L. E. and Brown, A. J. (2012). Fungal Hsp90: a biological transistor that tunes cellular outputs to thermal inputs. Nature Reviews Microbiology 10, 693704. doi: 10.1038/nrmicro2875.
Lin, S. J., Schranz, J. and Teutsch, S. M. (2001). Aspergillosis case-fatality rate: systematic review of the literature. Clinical Infectious Diseases 32, 358366. doi: 10.1086/318483.
Martinez-Ruiz, A., Villanueva, L., Gonzalez de Orduna, C., Lopez-Ferrer, D., Higueras, M. A., Tarin, C., Rodriguez-Crespo, I., Vazquez, J. and Lamas, S. (2005). S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. Proceedings of the National Academy of Sciences USA 102, 85258530. doi: 10.1073/pnas.0407294102.
McClellan, A. J., Xia, Y., Deutschbauer, A. M., Davis, R. W., Gerstein, M. and Frydman, J. (2007). Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches. Cell 131, 121135. doi: 10.1016/j.cell.2007.07.036.
Miller, L. G., Hajjeh, R. A. and Edwards, J. E. Jr. (2001). Estimating the cost of nosocomial candidemia in the United States. Clinical Infectious Diseases 32, 1110. doi: 10.1086/319613.
Millson, S. H., Truman, A. W., King, V., Prodromou, C., Pearl, L. H. and Piper, P. W. (2005). A two-hybrid screen of the yeast proteome for Hsp90 interactors uncovers a novel Hsp90 chaperone requirement in the activity of a stress-activated mitogen-activated protein kinase, Slt2p (Mpk1p). Eukaryotic Cell 4, 849860. doi: 10.1128/EC.4.5.849-860.2005.
Miyazaki, T., Inamine, T., Yamauchi, S., Nagayoshi, Y., Saijo, T., Izumikawa, K., Seki, M., Kakeya, H., Yamamoto, Y., Yanagihara, K., Miyazaki, Y. and Kohno, S. (2010 a). Role of the Slt2 mitogen-activated protein kinase pathway in cell wall integrity and virulence in Candida glabrata . FEMS Yeast Research 10, 343352. doi: 10.1111/j.1567-1364.2010.00611.x.
Miyazaki, T., Yamauchi, S., Inamine, T., Nagayoshi, Y., Saijo, T., Izumikawa, K., Seki, M., Kakeya, H., Yamamoto, Y., Yanagihara, K., Miyazaki, Y. and Kohno, S. (2010 b). Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata . Antimicrobial Agents and Chemotherapy 54, 16391643. doi: 10.1128/AAC.01364-09.
Mollapour, M., Tsutsumi, S., Donnelly, A. C., Beebe, K., Tokita, M. J., Lee, M. J., Lee, S., Morra, G., Bourboulia, D., Scroggins, B. T., Colombo, G., Blagg, B. S., Panaretou, B., Stetler-Stevenson, W. G., Trepel, J. B., Piper, P. W., Prodromou, C., Pearl, L. H. and Neckers, L. (2010). Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function. Molecular Cell 37, 333343.
Mollapour, M., Tsutsumi, S., Truman, A. W., Xu, W., Vaughan, C. K., Beebe, K., Konstantinova, A., Vourganti, S., Panaretou, B., Piper, P. W., Trepel, J. B., Prodromou, C., Pearl, L. H. and Neckers, L. (2011). Threonine 22 phosphorylation attenuates Hsp90 interaction with cochaperones and affects its chaperone activity. Molecular Cell 41, 672681. doi: 10.1016/j.molcel.2011.02.011.
Money, N. P. (2007). The Triumph of the Fungi: A Rotten History. Oxford University Press, New York, NY, USA.
Murphy, P. J., Morishima, Y., Kovacs, J. J., Yao, T. P. and Pratt, W. B. (2005). Regulation of the dynamics of Hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone. Journal of Biological Chemistry 280, 3379233799.
Neckers, L. and Workman, P. (2012). Hsp90 molecular chaperone inhibitors: are we there yet? Clinical Cancer Research 18, 6476. doi: 10.1158/1078-0432.CCR-11-1000.
Nett, J. and Andes, D. (2006). Candida albicans biofilm development, modeling a host-pathogen interaction. Current Opinion in Microbiology 9, 340345.
Noble, S. M., French, S., Kohn, L. A., Chen, V. and Johnson, A. D. (2010). Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nature Genetics 42, 590598. doi: 10.1038/ng.605.
Pallavi, R., Roy, N., Nageshan, R. K., Talukdar, P., Pavithra, S. R., Reddy, R., Venketesh, S., Kumar, R., Gupta, A. K., Singh, R. K., Yadav, S. C. and Tatu, U. (2010). Heat shock protein 90 as a drug target against protozoan infections: biochemical characterization of HSP90 from Plasmodium falciparum and Trypanosoma evansi and evaluation of its inhibitor as a candidate drug. Journal of Biological Chemistry 285, 3796437975. doi: 10.1074/jbc.M110.155317.
Patel, P. D., Yan, P., Seidler, P. M., Patel, H. J., Sun, W., Yang, C., Que, N. S., Taldone, T., Finotti, P., Stephani, R. A., Gewirth, D. T. and Chiosis, G. (2013). Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2. Nature Chemical Biology 9, 677684. doi: 10.1038/nchembio.1335.
Pfaller, M. A. and Diekema, D. J. (2007). Epidemiology of invasive candidiasis: a persistent public health problem. Clinical Microbiology Reviews 20, 133163.
Pfaller, M. A. and Diekema, D. J. (2010). Epidemiology of invasive mycoses in North America. Critical Reviews in Microbiology 36, 153.
Pizarro, J. C., Hills, T., Senisterra, G., Wernimont, A. K., Mackenzie, C., Norcross, N. R., Ferguson, M. A., Wyatt, P. G., Gilbert, I. H. and Hui, R. (2013). Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug design. PLoS Neglected Tropical Diseases 7, e2492. doi: 10.1371/journal.pntd.0002492.
Queitsch, C., Sangster, T. A. and Lindquist, S. (2002). Hsp90 as a capacitor of phenotypic variation. Nature 417, 618624.
Ramage, G., Mowat, E., Jones, B., Williams, C. and Lopez-Ribot, J. (2009). Our current understanding of fungal biofilms. Critical Reviews in Microbiology 35, 340355. doi: 10.3109/10408410903241436.
Reedy, J. L., Filler, S. G. and Heitman, J. (2010). Elucidating the Candida albicans calcineurin signaling cascade controlling stress response and virulence. Fungal Genetics and Biology 47, 107116. doi: 10.1016/j.fgb.2009.09.002.
Robbins, N., Uppuluri, P., Nett, J., Rajendran, R., Ramage, G., Lopez-Ribot, J. L., Andes, D. and Cowen, L. E. (2011). Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathogens 7, e1002257. doi: 10.1371/journal.ppat.1002257.
Robbins, N., Leach, M. D. and Cowen, L. E. (2012). Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance. Cell Reports 2, 878888. doi: 10.1016/j.celrep.2012.08.035.
Rutherford, S. L. (2003). Between genotype and phenotype: protein chaperones and evolvability. Nature Reviews Genetics 4, 263274.
Rutherford, S. L. and Lindquist, S. (1998). Hsp90 as a capacitor for morphological evolution. Nature 396, 336342.
Sanglard, D., Ischer, F., Marchetti, O., Entenza, J. and Bille, J. (2003). Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Molecular Microbiology 48, 959976.
Sangster, T. A., Lindquist, S. and Queitsch, C. (2004). Under cover: causes, effects and implications of Hsp90-mediated genetic capacitance. BioEssays 26, 348362.
Sangster, T. A., Salathia, N., Lee, H. N., Watanabe, E., Schellenberg, K., Morneau, K., Wang, H., Undurraga, S., Queitsch, C. and Lindquist, S. (2008 a). HSP90-buffered genetic variation is common in Arabidopsis thaliana . Proceedings of the National Academy of Sciences USA 105, 29692974. doi: 10.1073/pnas.0712210105.
Sangster, T. A., Salathia, N., Undurraga, S., Milo, R., Schellenberg, K., Lindquist, S. and Queitsch, C. (2008 b). HSP90 affects the expression of genetic variation and developmental stability in quantitative traits. Proceedings of the National Academy of Sciences USA 105, 29632968. doi: 10.1073/pnas.0712200105.
Scroggins, B. T., Robzyk, K., Wang, D., Marcu, M. G., Tsutsumi, S., Beebe, K., Cotter, R. J., Felts, S., Toft, D., Karnitz, L., Rosen, N. and Neckers, L. (2007). An acetylation site in the middle domain of Hsp90 regulates chaperone function. Molecular Cell 25, 151159.
Shahinas, D., Liang, M., Datti, A. and Pillai, D. R. (2010). A repurposing strategy identifies novel synergistic inhibitors of Plasmodium falciparum heat shock protein 90. Journal of Medicinal Chemistry 53, 35523557. doi: 10.1021/jm901796s.
Shahinas, D., Macmullin, G., Benedict, C., Crandall, I. and Pillai, D. R. (2012). Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin. Antimicrobial Agents and Chemotherapy 56, 42074213. doi: 10.1128/AAC.00328-12.
Shahinas, D., Folefoc, A., Taldone, T., Chiosis, G., Crandall, I. and Pillai, D. R. (2013). A purine analog synergizes with chloroquine (CQ) by targeting Plasmodium falciparum Hsp90 (PfHsp90). PLoS ONE 8, e75446. doi: 10.1371/journal.pone.0075446.
Shapiro, R. S., Uppuluri, P., Zaas, A. K., Collins, C., Senn, H., Perfect, J. R., Heitman, J. and Cowen, L. E. (2009). Hsp90 orchestrates temperature-dependent Candida albicans morphogenesis via Ras1-PKA signaling. Current Biology 19, 621629.
Shapiro, R. S., Robbins, N. and Cowen, L. E. (2011). Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiology and Molecular Biology Reviews 75, 213267. doi: 10.1128/MMBR.00045-10.
Shapiro, R. S., Sellam, A., Tebbji, F., Whiteway, M., Nantel, A. and Cowen, L. E. (2012 a). Pho85, Pcl1, and Hms1 signaling governs Candida albicans morphogenesis induced by high temperature or Hsp90 compromise. Current Biology 22, 461470. doi: 10.1016/j.cub.2012.01.062.
Shapiro, R. S., Zaas, A. K., Betancourt-Quiroz, M., Perfect, J. R. and Cowen, L. E. (2012 b). The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance. PLoS ONE 7, e44734. doi: 10.1371/journal.pone.0044734.
Singh, S. D., Robbins, N., Zaas, A. K., Schell, W. A., Perfect, J. R. and Cowen, L. E. (2009). Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathogens 5, e1000532. doi: 10.1371/journal.ppat.1000532.
Singh-Babak, S. D., Babak, T., Diezmann, S., Hill, J. A., Xie, J. L., Chen, Y. L., Poutanen, S. M., Rennie, R. P., Heitman, J. and Cowen, L. E. (2012). Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata . PLoS Pathogens 8, e1002718. doi: 10.1371/journal.ppat.1002718.
Sollars, V., Lu, X., Xiao, L., Wang, X., Garfinkel, M. D. and Ruden, D. M. (2003). Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution. Nature Genetics 33, 7074.
Southworth, D. R. and Agard, D. A. (2008). Species-dependent ensembles of conserved conformational states define the Hsp90 chaperone ATPase cycle. Molecular Cell 32, 631640. doi: 10.1016/j.molcel.2008.10.024.
Specchia, V., Piacentini, L., Tritto, P., Fanti, L., D'Alessandro, R., Palumbo, G., Pimpinelli, S. and Bozzetti, M. P. (2010). Hsp90 prevents phenotypic variation by suppressing the mutagenic activity of transposons. Nature 463, 662665. doi: 10.1038/nature08739.
Steinbach, W. J., Cramer, R. A. Jr., Perfect, B. Z., Asfaw, Y. G., Sauer, T. C., Najvar, L. K., Kirkpatrick, W. R., Patterson, T. F., Benjamin, D. K. Jr., Heitman, J. and Perfect, J. R. (2006). Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus . Eukaryotic Cell 5, 10911103.
Steinbach, W. J., Reedy, J. L., Cramer, R. A. Jr., Perfect, J. R. and Heitman, J. (2007). Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nature Reviews Microbiology 5, 418430.
Taipale, M., Jarosz, D. F. and Lindquist, S. (2010). HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nature Reviews Molecular Cell Biology 11, 515528. doi: 10.1038/nrm2918.
Tariq, M., Nussbaumer, U., Chen, Y., Beisel, C. and Paro, R. (2009). Trithorax requires Hsp90 for maintenance of active chromatin at sites of gene expression. Proceedings of the National Academy of Sciences USA 106, 11571162. doi: 10.1073/pnas.0809669106.
Trepel, J., Mollapour, M., Giaccone, G. and Neckers, L. (2010). Targeting the dynamic HSP90 complex in cancer. Nature Reviews Cancer 10, 537549. doi: 10.1038/nrc2887.
Xu, W., Mollapour, M., Prodromou, C., Wang, S., Scroggins, B. T., Palchick, Z., Beebe, K., Siderius, M., Lee, M. J., Couvillon, A., Trepel, J. B., Miyata, Y., Matts, R. and Neckers, L. (2012). Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine. Molecular Cell 47, 434443. doi: 10.1016/j.molcel.2012.05.015.
Xu, Y. and Lindquist, S. (1993). Heat-shock protein Hsp90 governs the activity of pp60v-src kinase. Proceedings of the National Academy of Sciences USA 90, 70747078.
Xu, Y., Singer, M. A. and Lindquist, S. (1999). Maturation of the tyrosine kinase c-src as a kinase and as a substrate depends on the molecular chaperone Hsp90. Proceedings of the National Academy of Sciences USA 96, 109114.
Zhang, J., Silao, F. G., Bigol, U. G., Bungay, A. A., Nicolas, M. G., Heitman, J. and Chen, Y. L. (2012). Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae . PLoS ONE 7, e44192. doi: 10.1371/journal.pone.0044192.
Zhao, R., Davey, M., Hsu, Y. C., Kaplanek, P., Tong, A., Parsons, A. B., Krogan, N., Cagney, G., Mai, D., Greenblatt, J., Boone, C., Emili, A. and Houry, W. A. (2005). Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the Hsp90 chaperone. Cell 120, 715727.
Zumla, A., Hafner, R., Lienhardt, C., Hoelscher, M. and Nunn, A. (2012). Advancing the development of tuberculosis therapy. Nature Reviews Drug Discovery 11, 171172. doi: 10.1038/nrd3694.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

  • ISSN: 0031-1820
  • EISSN: 1469-8161
  • URL: /core/journals/parasitology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 12
Total number of PDF views: 49 *
Loading metrics...

Abstract views

Total abstract views: 287 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd March 2018. This data will be updated every 24 hours.